Federated Hermes Inc. Sells 294,563 Shares of Healthpeak Properties, Inc. $DOC

Federated Hermes Inc. trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 22.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,018,276 shares of the real estate investment trust’s stock after selling 294,563 shares during the quarter. Federated Hermes Inc. owned about 0.15% of Healthpeak Properties worth $17,830,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of DOC. Victory Financial Group LLC acquired a new position in shares of Healthpeak Properties during the 2nd quarter worth approximately $176,000. Quantum Portfolio Management LLC boosted its stake in shares of Healthpeak Properties by 23.6% in the second quarter. Quantum Portfolio Management LLC now owns 19,832 shares of the real estate investment trust’s stock valued at $347,000 after buying an additional 3,786 shares during the period. Brown Advisory Inc. boosted its stake in shares of Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after buying an additional 1,415 shares during the period. Baird Financial Group Inc. grew its position in Healthpeak Properties by 38.5% during the second quarter. Baird Financial Group Inc. now owns 402,466 shares of the real estate investment trust’s stock worth $7,047,000 after buying an additional 111,807 shares in the last quarter. Finally, First Trust Advisors LP increased its stake in Healthpeak Properties by 266.1% during the 2nd quarter. First Trust Advisors LP now owns 2,363,039 shares of the real estate investment trust’s stock worth $41,377,000 after acquiring an additional 1,717,555 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $16.64 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.11. The stock has a market cap of $11.56 billion, a PE ratio of -332.63, a P/E/G ratio of 4.18 and a beta of 1.11. Healthpeak Properties, Inc. has a 12-month low of $16.45 and a 12-month high of $21.63. The business’s 50-day moving average price is $18.00 and its two-hundred day moving average price is $17.85.

Healthpeak Properties (NYSE:DOCGet Free Report) last posted its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The firm had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same quarter in the prior year, the business earned $0.45 earnings per share. The business’s revenue for the quarter was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be given a dividend of $0.1017 per share. The ex-dividend date is Friday, December 19th. This represents a c) annualized dividend and a dividend yield of 7.3%. Healthpeak Properties’s dividend payout ratio is presently -2,440.00%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on DOC. Wells Fargo & Company upped their target price on Healthpeak Properties from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th. Cantor Fitzgerald initiated coverage on Healthpeak Properties in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. Morgan Stanley reduced their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating on the stock in a research note on Friday, August 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a report on Monday. Finally, Evercore ISI set a $22.00 price target on shares of Healthpeak Properties in a report on Monday, September 15th. Six research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.60.

Read Our Latest Analysis on Healthpeak Properties

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Recommended Stories

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.